Koshkareva Yekaterina, Liu Jeffrey C, Lango Miriam, Galloway Thomas, Gaughan John P, Ridge John A
Division of Otolaryngology, Department of Surgery, Cooper University Hospital, 3 Cooper Plaza, Suite 411, Camden, NJ 08034, USA.
Ear Nose Throat J. 2016 Oct-Nov;95(10-11):E6-E11. doi: 10.1177/014556131609510-1103.
We conducted a retrospective study to determine the incidence and treatment outcomes of neck metastases in patients with squamous cell carcinoma (SCC) of the hard palate and/or maxillary alveolus after surgical excision of the primary tumor. We also sought to identify any risk factors for recurrence. Our study population was made up of 20 patients-9 men and 11 women, aged 46 to 88 years (mean: 72.6)-who had undergone excision of an SCC of the hard palate and/or maxillary alveolus at a tertiary care cancer center over a 7-year period. Half of all patients were former tobacco users. Of the 20 tumors, 10 involved the maxillary alveolus, 4 involved the hard palate, and 6 involved both sites. Three patients were clinically categorized as T1, 9 as T2, 6 as T3, and 2 as T4; pathologically, 8 tumors were categorized as T4a. In addition to maxillectomy, a neck dissection was performed in 7 patients-4 therapeutically and 3 electively. Eight of 20 patients experienced a recurrence: 4 local, 6 regional, and 2 distant (several patients had a recurrence at more than one site). Univariate analysis identified perineural invasion (p = 0.04) as a statistically significant risk factor for recurrence. Of 14 patients with a clinicopathologically negative neck, 5 (36%) developed a cervical recurrence, and 4 of them died of their disease. An advanced stage (T4 vs. <T4) was not significantly correlated with the risk of regional metastasis (p = 0.58). The rate of occult nodal metastasis in clinically and radiologically N0 necks was high. Clinical and radiologic understaging was common, and regional recurrences frequently resulted in death. We conclude that elective nodal evaluation and treatment of the neck warrants strong consideration for most patients with cancer of the hard palate and/or maxillary alveolus.
我们进行了一项回顾性研究,以确定硬腭和/或上颌牙槽鳞状细胞癌(SCC)患者在原发肿瘤手术切除后颈部转移的发生率和治疗结果。我们还试图确定任何复发的危险因素。我们的研究对象包括20例患者,其中9例男性和11例女性,年龄在46至88岁之间(平均72.6岁),他们在一家三级医疗癌症中心接受了为期7年的硬腭和/或上颌牙槽SCC切除术。所有患者中有一半曾是吸烟者。在这20个肿瘤中,10个累及上颌牙槽,4个累及硬腭,6个累及两个部位。3例患者临床分类为T1,9例为T2,6例为T3,2例为T4;病理上,8个肿瘤分类为T4a。除上颌骨切除术外,7例患者进行了颈部清扫术,其中4例为治疗性清扫,3例为选择性清扫。20例患者中有8例出现复发:4例为局部复发,6例为区域复发,2例为远处复发(几名患者在多个部位复发)。单因素分析确定神经周围侵犯(p = 0.04)是复发的统计学显著危险因素。在14例颈部临床病理检查阴性的患者中,5例(36%)发生颈部复发,其中4例死于疾病。晚期(T4 vs. <T4)与区域转移风险无显著相关性(p = 0.58)。临床和放射学检查为N0的颈部隐匿性淋巴结转移率较高。临床和放射学分期不足很常见,区域复发常导致死亡。我们得出结论,对于大多数硬腭和/或上颌牙槽癌患者,选择性颈部淋巴结评估和治疗值得高度考虑。